Results 131 to 140 of about 95,906 (268)
ERBB Receptor Regulation of ESX/ELF3 Promotes Invasion in Breast Epithelial Cells [PDF]
, 2010 Jean Philippe Coppé +8 more
openalex +1 more source
Nano‐Mediated Fluorescence Switching for Epidermal Growth Factor Receptor Detection
Cell Proliferation, Volume 58, Issue 12, December 2025.This study presents Cy3‐AptEGFR@BPNSs, a novel nano‐detector for real‐time, visual monitoring of EGFR expression in cancer cells. Addressing the limitations of current methods, this detector utilises fluorescence quenching/recovery, providing high specificity and sensitivity, with fluorescence intensity proportional to EGFR levels.
Xin Fu +11 more
wiley +1 more source
Tumour Cell Size Control and Its Impact on Tumour Cell Function
Cell Proliferation, Volume 58, Issue 12, December 2025.The regulatory mechanism of the size of tumour cells and its impact on the functions of tumour cells, as well as a summary of potential therapeutic targets for the corresponding mechanisms. ABSTRACT Cell size is an important component of cell morphological characteristics.
Min Zhou, Mei Zhou, Yang Jin
wiley +1 more source
Journal of Cellular and Molecular Medicine, Volume 29, Issue 23, December 2025.ABSTRACT The competing endogenous RNA hypothesis offers new insights into tumour progression, yet its role in posttreatment nasopharyngeal carcinoma relapse remains unclear. This study constructed ceRNA networks to identify molecular markers associated with NPC relapse.
Qihong Liu +9 more
wiley +1 more source
C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro [PDF]
, 2003 Takashi Kusakari +8 more
openalex +1 more source
Inhibition of ErbB2 mitigates secondary denervation after traumatic muscle injury
The Journal of Physiology, Volume 603, Issue 23, Page 7531-7548, December 1, 2025.Abstract figure legend Our study evaluated the therapeutic potential of ErbB2 inhibition (Herceptin) after volumetric muscle loss (VML) injury, primarily evaluating improvements at the neuromuscular junctions (NMJ). A full thickness model of VML injury to the tibialis anterior muscle of adult Lewis rats was used, and treatments included Herceptin, a ...
Jacob R. Sorensen +6 more
wiley +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1998 目的: 研究 c -erbB-2, c-erbB-4 原癌基因过度表达与乳腺癌发生及其病理参数的相关关系。方法: 对 122 例乳腺疾病石蜡切块,其 中 80 例乳腺癌, 16 例乳腺纤维腺瘤, 9 例乳腺纤维囊性病, 17 例乳腺癌转移淋巴结均采用免疫组化( LSAB 法)结合计算机图象分析研究原癌 基因产物 c-erbB-2, c-erbB-4的表达情况。结果: c-erbB-2 在乳腺癌中存在过度表达, P
doaj
Expression and Characterization of Kinase‐active v‐erbB Protein Using a Baculovirus Vector System [PDF]
, 1992 Kaoru Morishita +6 more
openalex +1 more source
The Dipole Potential Influences the Clustering of ErbB Proteins [PDF]
, 2015 Tamás Kovács +3 more
openalex +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1996 应用单克隆抗体Ｃ－ｅｒｂＢ－２肿瘤蛋白及免疫组化（ＬＳＡＢ）法，对８４例乳腺浸润性导管癌作Ｃ－ｅｒｂＢ－２癌基因蛋白产物表达（简称Ｃ－ｅｒｂＢ－２表达）检测并与随诊资料进行比较分析，结果（１）Ｃ－ｅｒｂＢ－２在本组病例的表达率为５５．９％（４７／８４）。（２）Ｃ－ｅｒｂＢ－２表达与肿瘤的ＴＮＭ分期、复发／远必转移、５ａ生存率无相关性（Ｐ＞０．０５）、而仅与腋淋巴结转移状况和２ａ死亡率有关（Ｐ＜０．００５及Ｐ＜０．０５）。（３）有／无淋巴结转移病例的Ｃ－ｅｒｂＢ－２表达与患者的预后均无关（Ｐ＞０．７５ ...
doaj